{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:52:15Z","timestamp":1789548735645,"version":"build-2803163510"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/gme.0b013e318271f5e7","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T06:47:07Z","timestamp":1356590827000},"page":"138-145","source":"Crossref","is-referenced-by-count":85,"title":["Breast density changes in a randomized controlled trial evaluating bazedoxifene\/conjugated estrogens"],"prefix":"10.1097","volume":"20","author":[{"given":"Jennifer A.","family":"Harvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn V.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund C.","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadi A.","family":"Chines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mirkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S1470-2045(05)70390-9","article-title":"Mammographic breast density as an intermediate phenotype for breast cancer.","volume":"6","author":"Boyd","year":"2005","journal-title":"Lancet Oncol"},{"key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0b013e328341e2ce","article-title":"Mammographic density as a risk factor for breast cancer in a German case-control study.","volume":"20","author":"Heusinger","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","article-title":"Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.","volume":"15","author":"McCormack","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-7-20210211","first-page":"332","article-title":"Mammographic density and breast cancer in three ethnic groups.","volume":"12","author":"Ursin","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","article-title":"Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.","volume":"92","author":"Mandelson","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.6004\/jnccn.2010.0085","article-title":"Mammographic breast density: effect on imaging and breast cancer risk.","volume":"8","author":"Pinsky","year":"2010","journal-title":"J Natl Compr Cancer Netw"},{"key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1447-0756.2006.00402.x","article-title":"Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.","volume":"32","author":"Topal","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/09513590400030046","article-title":"Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.","volume":"21","author":"Santen","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/jnci\/89.21.1623","article-title":"Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.","volume":"89","author":"Harvey","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R11-7-20210211","first-page":"513","article-title":"Effect of estrogen-progestin and estrogen on mammographic density.","volume":"52","author":"Kaewrudee","year":"2007","journal-title":"J Reprod Med"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1028-4559(10)60091-5","article-title":"Factors that influence changes in mammographic density with postmenopausal hormone therapy.","volume":"49","author":"Chen","year":"2010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2003.21","article-title":"Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women.","volume":"188","author":"Jackson","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/gme.0b013e3181a7fb1e","article-title":"The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis.","volume":"16","author":"Harvey","year":"2009","journal-title":"Menopause"},{"key":"R15-7-20210211","first-page":"863","article-title":"Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.","volume":"8","author":"Atkinson","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-7-20210211","first-page":"917","article-title":"Effect of tamoxifen on mammographic density.","volume":"9","author":"Chow","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/93.1.51","article-title":"Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.","volume":"93","author":"Freedman","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.gme.0000233493.20712.ad","article-title":"Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.","volume":"13","author":"Lasco","year":"2006","journal-title":"Menopause"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jnci\/djk049","article-title":"Long-term results of tamoxifen prophylaxis for breast cancer96-month follow-up of the randomized IBIS-I trial.","volume":"99","author":"Cuzick","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/jnci\/djr079","article-title":"Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.","volume":"103","author":"Cuzick","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R21-7-20210211","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1210\/en.2008-0817","article-title":"The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention.","volume":"149","author":"Kharode","year":"2008","journal-title":"Endocrinology"},{"key":"R22-7-20210211","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1210\/me.2008-0366","article-title":"Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.","volume":"23","author":"Berrodin","year":"2009","journal-title":"Mol Endocrinol"},{"key":"R23-7-20210211","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifeneconjugated estrogens for osteoporosis prevention in at-risk postmenopausal women.","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"R24-7-20210211","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifeneconjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil Steril"},{"key":"R25-7-20210211","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/gme.0b013e3181a7df0d","article-title":"Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifeneconjugated estrogens: a randomized, controlled trial.","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"R26-7-20210211","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A randomized, placebo- and active-controlled trial of bazedoxifeneconjugated estrogens for treatment of moderate to severe vulvarvaginal atrophy in postmenopausal women.","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"key":"R27-7-20210211","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifeneconjugated estrogens as a menopausal therapy.","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertil Steril"},{"key":"R30-7-20210211","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2009.05.093","article-title":"Bazedoxifeneconjugated estrogens (BZACE): incidence of uterine bleeding in postmenopausal women.","volume":"92","author":"Archer","year":"2009","journal-title":"Fertil Steril"},{"key":"R31-7-20210211","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1148\/radiographics.18.6.9821201","article-title":"Analysis of mammographic density and breast cancer risk from digitized mammograms.","volume":"18","author":"Byng","year":"1998","journal-title":"Radiographics"},{"key":"R32-7-20210211","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jnci\/87.9.670","article-title":"Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study.","volume":"87","author":"Boyd","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R33-7-20210211","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/gme.0b013e3181d0f6b9","article-title":"Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.","volume":"17","year":"2010","journal-title":"Menopause"},{"key":"R34-7-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R35-7-20210211","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Womens Health Initiative randomized trial.","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"R36-7-20210211","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2214\/ajr.163.2.8037021","article-title":"Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.","volume":"163","author":"McNicholas","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"R37-7-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djr225","article-title":"Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.","volume":"103","author":"Yaghjyan","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R38-7-20210211","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/aje\/kwn063","article-title":"Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study.","volume":"167","author":"Kelemen","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R39-7-20210211","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/en.2008-1210","article-title":"Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.","volume":"150","author":"Peano","year":"2009","journal-title":"Endocrinology"},{"key":"R40-7-20210211","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsbmb.2009.11.003","article-title":"Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.","volume":"118","author":"Chang","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R41-7-20210211","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.maturitas.2009.07.009","article-title":"Hormone therapy, mammographic density, and breast cancer risk.","volume":"64","author":"Martin","year":"2009","journal-title":"Maturitas"},{"key":"R42-7-20210211","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/dji279","article-title":"Estrogen-plus-progestin use and mammographic density in postmenopausal women: Womens Health Initiative randomized trial.","volume":"97","author":"McTiernan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R43-7-20210211","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1158\/1055-9965.EPI-06-0290","article-title":"Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.","volume":"15","author":"Chiarelli","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R44-7-20210211","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1200\/JCO.2010.33.7964","article-title":"Mammographic density, response to hormones, and breast cancer risk.","volume":"29","author":"Boyd","year":"2011","journal-title":"J Clin Oncol"},{"key":"R45-7-20210211","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/gme.0b013e3181c29e56","article-title":"The effects of raloxifene on mammographic breast density: a review of clinical trials.","volume":"17","author":"Pearman","year":"2010","journal-title":"Menopause"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GME.0b013e318271f5e7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:58Z","timestamp":1620952858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201302000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318271f5e7","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}